To compare the effectiveness of gabapentin with aprepitant in the control of delayed nausea & vomiting associated with level 3, 4 or 5 emetogenic chemotherapy in pts who experienced delayed nausea and/or vomiting during their first cycle of chemotherapy. 1 month [clinicaltrials_resource:64caf82d43c7388115f7d5b4c49ef510]
Gabapentin 300mg PO QHS day -2; 300mg PO BID day -1; 300mg PO TID days 0 through +5.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
To compare the effectiveness of gabapentin with aprepitant in the control of delayed nausea & vomiting associated with level 3, 4 or 5 emetogenic chemotherapy in pts who experienced delayed nausea and/or vomiting during their first cycle of chemotherapy. 1 month [clinicaltrials_resource:64caf82d43c7388115f7d5b4c49ef510]
Gabapentin 300mg PO QHS day -2; 300mg PO BID day -1; 300mg PO TID days 0 through +5.
Bio2RDF identifier
64caf82d43c7388115f7d5b4c49ef510
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:64caf82d43c7388115f7d5b4c49ef510
measure [clinicaltrials_vocabulary:measure]
To compare the effectiveness o ...... r first cycle of chemotherapy.
time frame [clinicaltrials_vocabulary:time-frame]
description
Gabapentin 300mg PO QHS day -2; 300mg PO BID day -1; 300mg PO TID days 0 through +5.
identifier
clinicaltrials_resource:64caf82d43c7388115f7d5b4c49ef510
title
To compare the effectiveness o ...... cycle of chemotherapy. 1 month
@en
type
label
To compare the effectiveness o ...... af82d43c7388115f7d5b4c49ef510]
@en